Nurix Therapeutics Inc
Biotechnology
Healthcare
NRIX
83.56 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
8.44
52 week high
28.14
high
8.44
52 week low
0.00
low
8.20
growth
-67.84 %
previous Close
8.43
P/E ratio
market cap
887 M
div yield
0
usd
Feb 2025
qoq
revenue
18.45 M
38.91 %
net incoming
-56.35 M
3.75 %
eps
0.00 %
10.67 %
eps surprise
12.00 %
net profit margin
-305.38 %
135.00 %
operating incoming
-62.86 M
2.77 %
net change in cash
-34.08 M
-411.16 %
cash on hand
75.92 M
-30.98 %
cost of revenue
4.13 M
0.00 %
top top